Publications

刘卢路, Lei Wang, Li Chen, Yiling Ding, Qilin Zhang, Yamin Shu (2023). Cost-effectiveness of sintilimab plus chemotherapy versus chemotherapy alone as first-line treatment of locally advanced or metastatic oesophageal squamous cell carcinoma. Frontiers in Immunology, 14.

Yamin Shu, Yiling Ding, 刘卢路, Qilin Zhang (2023). Cardiac adverse events associated with quetiapine Disproportionality analysis of FDA adverse event reporting system. CNS Neuroscience & Therapeutics, 14.

刘卢路, Jia Chen, Lei Wang, Chen Chen, Li Chen (2022). Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions A real-world disproportionality study based on FDA adverse event reporting system database. Frontiers in Endocrinology, 13.

Liu Lulu, Zhang Jiahui, Zhang Nuoya, Ruan Zhen, He Xiaoning (2021). The Real-World Clinical Effectiveness of GLP-1 Receptor Agonist Liraglutide. In Virtual ISPOR Europe 2021.

项目海报 ISPOR收录页面

刘卢路, 章琦蕴芮, 王志远, 陈中翎, 陈拂尘, 陈力, 邱佳钰 (2019). 基于真实世界数据的硝苯地平不良反应信号挖掘研究. 中南药学, 17(07).